Investor and Director
Named by MIT’s Technology Review as one of the world’s top entrepreneurs, Carmichael has honed a unique business model of licensing university technology and commercializing it through targeted partnerships with Fortune 500 companies. Before founding Material Impact, Carmichael was a General Partner at North Bridge Venture Partners, President, and CEO of Arsenal Medical, and served in leadership roles at GelTex Pharmaceuticals (acquired by Genzyme for $1.3 billion), and Dow Chemical. A member of the Investment Committee for Breakthrough Energy Ventures, he is also co-founder and chairman of Diagnostics For All and serves on the boards for the National Venture Capital Association and Massachusetts General Hospital Physician Organization. A trustee of Duke University, in his free time he enjoys coaching his kids’ lacrosse teams and taking weekly spin classes. As a former Trustee of the Berklee College of Music and an Overseer of the Boston Symphony Orchestra, Carmichael is a major supporter of the local music community in Boston.